Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
10 participants
INTERVENTIONAL
2011-03-31
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
FGF21 and Fructose Challenge in Humans
NCT02884791
Effects of Fructose Restriction on Liver Steatosis
NCT03067428
Effect of Dietary Fat When Eaten With Fructose Versus Glucose
NCT01061346
The Effects of Increased Fructose Ingestion on FGF-21 Levels in Humans
NCT03201549
Genetic-specific Effects of Fructose on Liver Lipogenesis
NCT03783195
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Fructose
Oral Fructose Challenge (75 g fructose in 500 ml water) followed by 75 minutes 31P MRS
Fructose
Oral Fructose Challenge (75 g fructose in 500 ml water) following overnight fast
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fructose
Oral Fructose Challenge (75 g fructose in 500 ml water) following overnight fast
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18 - 30
* BMI 20 - 27 kg/m\^2
* Healthy
Exclusion Criteria
* Liver disease or Metabolic Disorders
* Metal implants (not suitable for MRI)
18 Years
30 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Biotechnology and Biological Sciences Research Council
OTHER
Unilever R&D
INDUSTRY
Stephen Bawden
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Stephen Bawden
CASE studentship researcher
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Luca Marciani
Role: PRINCIPAL_INVESTIGATOR
University of Nottingham
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Nottingham
Nottingham, Nottinghamshire, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A32006_FRU
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.